Zentek (TSXV:ZEN) Inventories, Other : C$0.90 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Zentek Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Zentek's other inventories for the quarter that ended in Dec. 2024 was C$0.90 Mil.

Zentek's quarterly other inventories declined from Jun. 2024 (C$1.41 Mil) to Sep. 2024 (C$1.06 Mil) and declined from Sep. 2024 (C$1.06 Mil) to Dec. 2024 (C$0.90 Mil).

Zentek's annual other inventories declined from Mar. 2022 (C$0.00 Mil) to Mar. 2023 (C$-0.00 Mil) but then increased from Mar. 2023 (C$-0.00 Mil) to Mar. 2024 (C$1.42 Mil).

Zentek Inventories, Other Historical Data

The historical data trend for Zentek's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek Inventories, Other Chart

Zentek Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Inventories, Other

Get a 7-Day Free Trial

1.42

Zentek Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Inventories, Other	Get a 7-Day Free Trial															-	1.42	1.41	1.06	0.90

Zentek Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Zentek Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » Inventories, Other

Comparable Companies

Traded in Other Exchanges

ZTEK:USA ZAY:Germany

Address

24 Corporate Court, Guelph, ON, CAN, N1G 5G5

Website

https://www.zentek.com

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Executives

Colin Stuart Van Der Kuur	Senior Officer
Francis Jacques Dubé	Director
Ilse Treurnicht	Director
John Snisarenko	Director
Brian Gerald Bosse	Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Gregory Fenton	Director
Eric Wallman	Director